ProKidney GAAP EPS of -$0.12 beats by $0.02, revenue of $0.22M beats by $0.18M
Source: SeekingAlpha
2025-11-10 17:01:03 ET
- ProKidney press release ( PROK ): Q3 GAAP EPS of -$0.12 beats by $0.02 .
- Revenue of $0.22M beats by $0.18M .
- Liquidity: Cash, cash equivalents and marketable securities as of September 30, 2025, totaled $271.7 million, compared to $358.3 million on December 31, 2024. ProKidney expects that its existing cash, cash equivalents and marketable securities held on September 30, 2025, will enable the Company to fund its operating expenses and capital expenditure requirements into mid-2027.
- Shares +1.49% AH.
Read the full article on Seeking Alpha
For further details see:
ProKidney GAAP EPS of -$0.12 beats by $0.02, revenue of $0.22M beats by $0.18M
ProKidney Corp.
NASDAQ: PROK
PROK Trading
6.02% G/L:
$2.555 Last:
515,024 Volume:
$2.43 Open:
PROK Latest News
January 06, 2026 07:30:00 am
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
PROK Stock Data
$604,677,102
98,372,842
N/A
82
N/A
Biotechnology & Life Sciences
Healthcare
US
Winston-Salem
